Jacob Søby

MD, PhD-student, Department of Cardiology, Gødstrup Hospital, Aarhus University. Myocardial perfusion imaging & chronic coronary syndrome

[Journal of Nuclear Cardiology @JNCjournal]

MBF and MFR measured by ⁸²Rb and [¹⁵O]H₂O PET differ systematically. In a pooled analysis of 4 studies, an MFR of 2 with ⁸²Rb corresponds to ~2.4–2.6 with [¹⁵O]H₂O PET—prognostic cut-offs must be tracer-specific and require further validation for [¹⁵O]H₂O PET. #CVNuc #ThinkPET @JacobSoeby @lostrasmussen @LTolbod @mortenboettcher @DANNICADtrial @AUHdk

Read now👉https://t.co/wJrijqoeOJ

[Jacob Søby @JacobSoeby]

@SimonWinther5 @WestraJelmer @h_evald @larsgormsen @mortenboettcher

[Jacob Søby @JacobSoeby]

In patients with moderate coronary stenoses, MRR seems to predict symptomatic and perfusion benefit of revascularization. Proud @DANNICADtrial team at #ESCCongress2024 @lostrasmussen @DCAcademyDK @ehj_ed. Paper out in the EHJ now at https://t.co/L6fhAy5rYA

[C. Michael Gibson MD @CMichaelGibson]

Microvascular resistance reserve (MRR) associated with rates of angina after revascularization in pts with moderate coronary stenosis beyond CRF or FFR. Watch Dr. Laust Dupont Rasmussen present results of Dan-NICAD study presented at #ESCCongress

[The Dan-NICAD trials @DANNICADtrial]

From the @DANNICAD investigators as #latebreaking science @escardio 2024 🇬🇧

Assessment of the microvascular resistance reserve for predicting the effect of revascularization in patients with moderate coronary stenoses

📅 September 1st, 17:30
📍Bishkek
🎙️@lostrasmussen

[The Dan-NICAD trials @DANNICADtrial]

🔖 Biomarkers for identification of high-risk coronary artery plaques in patients with suspected coronary artery disease

📍@journalCCT

https://t.co/6G057mnk09

[The Dan-NICAD trials @DANNICADtrial]

Out in @circlecvi: Myocardial Blood Flow by Magnetic Resonance in Patients With Suspected Coronary Stenosis: Comparison to PET and Invasive Physiology.

https://t.co/fGD7veQnzj

[Jacob Søby @JacobSoeby]

Let’s go! #ICNCCT2024 @DANNICADtrial @lostrasmussen @mortenboettcher @SimonWinther5

[The Dan-NICAD trials @DANNICADtrial]

Calcium Scoring Improves Clinical Management in Patients With Low Clinical Likelihood of Coronary Artery Disease

@lostrasmussen @mortenboettcher @SimonWinther5 @SamEmil @JuhaniKnuuti @pamelasdouglas @BFoldyna

https://t.co/38nNjUFsAJ

[Morten Bøttcher @mortenboettcher]

https://t.co/fjBKHNoOxo

[Jacob Søby @JacobSoeby]

@Medicinmanden Deltagerne blev fulgt i 12 uger efter PCI/placebo hvor de fik øget deres antianginøse behandling hvis der var behov herfor - dermed var det kun 2 uger helt uden medicin op til procedure.

[Jacob Søby @JacobSoeby]

@Medicinmanden Hvis PCI skal bevare sin plads i behandlingen af stabil angina, er det derfor yderst relevant at kende den placebokontrollerede effekt heraf - ogs set i lyset af økonomi og risici.

[John Mandrola, MD @drjohnm]

The Euro Society of Hypertension recently upgraded B-blockers to first-line Rx

In the Lancet, writing w Drs Messerli and Bangalore, we argue against this mostly convenience recommendation

Link free to Dec 2 https://t.co/hts8NmZZTr

#CardioTwitter #neurotwitter @kaulcsmc

[Laust Dupont Rasmussen @lostrasmussen]

Appreciate the great editorial @Heart_BMJ from @marcusflather et al. on our novel ExECG model for pre-test assessment of stable chest pain patients.

📖: https://t.co/iKo4fZuXFy

Back to the future!🚀

@mortenboettcher @SimonWinther5 @JuhaniKnuuti @cvrints @SamEmil

[Evald Høj Christiansen @h_evald]

PhD student Lene N Andreasen presented the OCTOBER Trial showing superiority of using OCT in guiding complex bifurcation PCI and had simultaneous NEJM publication. Great achievent Lene and congratulations to the whole OCTOBER organisation. 👏👏👏

DOI: 10.1056/NEJMoa2307770

[The Dan-NICAD trials @DANNICADtrial]

Late-breaking @ #ESCCongress: similar moderate sensitivities but higher specificity of PET #cvNUK by 82Rb vs. 15OPET against invasive FFR.

Importantly, both tracers had high sensitivities against severe stenosis with potential of causing myocardial ischemia.

🔴: 82Rb
🟢: 15O

[Laust Dupont Rasmussen @lostrasmussen]

Of press: a novel exercise ECG-weighted clinical likelihood model improves discrimination and potentially management of de novo chest pain patients.

📖: @Heart_BMJ

Huge 🙌🏻 to @SimonWinther5 @mortenboettcher @SamEmil @JuhaniKnuuti @cvrints ➕Koen Nieman and David Newby.

[Laust Dupont Rasmussen @lostrasmussen]

Exited for the incoming results @escardio 2023 📍Amsterdam. @

@SimonWinther5 @mortenboettcher @larsgormsen @WestraJelmer @h_evald @SalmaRKarim @MetteNyegaard